Digest Network Come funziona
Network
/
Società
Ab
Non verificato

AbbVie

Di cosa scriviamo

Ecologia/Salute ambientaleEventiFitnessMedicina - VarieSalute

4 comunicati stampa

Guarda tutti i comunicati
12/06/2026
Salute
Fitness
Fiere
Eventi
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year Results
Fonte
AbbVie
Emittente
PR News Wire
1.00
0
08/06/2026
Salute
Fitness
Fiere
Eventi
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026
Fonte
AbbVie
Emittente
PR News Wire
1.00
0
02/06/2026
Salute
Fitness
Medicina - Varie
AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Acute Treatment of Migraine in Adults
Fonte
AbbVie
Emittente
PR News Wire
1.00
0
29/05/2026
Salute
Fitness
Amministrazione Pubblica
Medicina - Varie
AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia
Fonte
AbbVie
Emittente
PR News Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0